skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 65  for All Library Resources

Results 1 2 3 4 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cerebral Cavernous Malformation: From Mechanism to Therapy
Material Type:
Article
Add to My Research

Cerebral Cavernous Malformation: From Mechanism to Therapy

Circulation research, 2021-06, Vol.129 (1), p.195-215 [Peer Reviewed Journal]

ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/circresaha.121.318174 ;PMID: 34166073

Full text available

2
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism
Material Type:
Article
Add to My Research

PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism

Nature (London), 2021-06, Vol.594 (7862), p.271-276 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03562-8 ;PMID: 33910229

Full text available

3
Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling
Material Type:
Article
Add to My Research

Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling

Nature (London), 2016-04, Vol.532 (7597), p.122-126 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Apr 7, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature17178 ;PMID: 27027284 ;CODEN: NATUAS

Full text available

4
β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations
Material Type:
Article
Add to My Research

β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations

The FASEB journal, 2022-12, Vol.36 (12), p.e22629-n/a [Peer Reviewed Journal]

2022 Federation of American Societies for Experimental Biology. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0892-6638 ;EISSN: 1530-6860 ;DOI: 10.1096/fj.202200907RR ;PMID: 36349990

Full text available

5
Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation
Material Type:
Article
Add to My Research

Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation

Blood, 2022-11, Vol.140 (20), p.2154-2169 [Peer Reviewed Journal]

2022 The American Society of Hematology ;2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021015350 ;PMID: 35981497

Full text available

6
Loss of the transcription factor RBPJ induces disease-promoting properties in brain pericytes
Material Type:
Article
Add to My Research

Loss of the transcription factor RBPJ induces disease-promoting properties in brain pericytes

Nature communications, 2019-06, Vol.10 (1), p.2817-19, Article 2817 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-10643-w ;PMID: 31249304

Full text available

7
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice
Material Type:
Article
Add to My Research

Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice

Blood, 2019-01, Vol.133 (3), p.193-204 [Peer Reviewed Journal]

2019 American Society of Hematology ;2019 by The American Society of Hematology. ;2019 by The American Society of Hematology 2019 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-06-856062 ;PMID: 30442679

Full text available

8
Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican
Material Type:
Article
Add to My Research

Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican

The Journal of experimental medicine, 2020-10, Vol.217 (10) [Peer Reviewed Journal]

2020 Hong et al. ;2020 Hong et al. 2020 ;ISSN: 0022-1007 ;EISSN: 1540-9538 ;DOI: 10.1084/jem.20200140 ;PMID: 32648916

Full text available

9
Deregulated TGF-β/BMP Signaling in Vascular Malformations
Material Type:
Article
Add to My Research

Deregulated TGF-β/BMP Signaling in Vascular Malformations

Circulation research, 2017-09, Vol.121 (8), p.981-999 [Peer Reviewed Journal]

2017 American Heart Association, Inc. ;Copyright Lippincott Williams & Wilkins Ovid Technologies Sep 29, 2017 ;ISSN: 0009-7330 ;ISSN: 1524-4571 ;EISSN: 1524-4571 ;DOI: 10.1161/CIRCRESAHA.117.309930 ;PMID: 28963191

Full text available

10
Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation
Material Type:
Article
Add to My Research

Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation

Nature medicine, 2016-09, Vol.22 (9), p.1033-1042 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2016 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/nm.4169 ;PMID: 27548575

Full text available

11
Regulation of β1 Integrin-Klf2-Mediated Angiogenesis by CCM Proteins
Material Type:
Article
Add to My Research

Regulation of β1 Integrin-Klf2-Mediated Angiogenesis by CCM Proteins

Developmental cell, 2015-01, Vol.32 (2), p.181-190 [Peer Reviewed Journal]

2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1534-5807 ;EISSN: 1878-1551 ;DOI: 10.1016/j.devcel.2014.12.016 ;PMID: 25625207

Full text available

12
Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations
Material Type:
Article
Add to My Research

Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations

The Journal of experimental medicine, 2017-11, Vol.214 (11), p.3331-3346 [Peer Reviewed Journal]

2017 Lopez-Ramirez et al. ;Copyright Rockefeller University Press Nov 6, 2017 ;2017 Lopez-Ramirez et al. 2017 ;ISSN: 0022-1007 ;EISSN: 1540-9538 ;DOI: 10.1084/jem.20171178 ;PMID: 28970240

Full text available

13
Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure
Material Type:
Article
Add to My Research

Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure

The FASEB journal, 2018-05, Vol.32 (5), p.2615-2629 [Peer Reviewed Journal]

FASEB ;FASEB 2018 FASEB ;ISSN: 0892-6638 ;EISSN: 1530-6860 ;DOI: 10.1096/fj.201700699R ;PMID: 29295866

Full text available

14
Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
Material Type:
Article
Add to My Research

Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models

The Journal of clinical investigation, 2021-02, Vol.131 (3) [Peer Reviewed Journal]

2021 American Society for Clinical Investigation 2021 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI144893 ;PMID: 33301422

Full text available

15
Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model
Material Type:
Article
Add to My Research

Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model

Nature communications, 2021-01, Vol.12 (1), p.504-504, Article 504 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-20774-0 ;PMID: 33495460

Full text available

16
Deciphering impact of single nucleotide polymorphisms on cotranscriptional modification in CCM gene mRNAs
Material Type:
Article
Add to My Research

Deciphering impact of single nucleotide polymorphisms on cotranscriptional modification in CCM gene mRNAs

American Journal of Physiology: Cell Physiology, 2022-10, Vol.323 (4), p.C1274-C1284 [Peer Reviewed Journal]

ISSN: 0363-6143 ;EISSN: 1522-1563 ;DOI: 10.1152/ajpcell.00279.2022 ;PMID: 36094437

Full text available

17
Inflammation and neutrophil extracellular traps in cerebral cavernous malformation
Material Type:
Article
Add to My Research

Inflammation and neutrophil extracellular traps in cerebral cavernous malformation

Cellular and molecular life sciences : CMLS, 2022-04, Vol.79 (4), p.206-206, Article 206 [Peer Reviewed Journal]

The Author(s) 2022. corrected publication 2022 ;2022. The Author(s). ;The Author(s) 2022. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022, corrected publication 2022 ;ISSN: 1420-682X ;ISSN: 1420-9071 ;EISSN: 1420-9071 ;DOI: 10.1007/s00018-022-04224-2 ;PMID: 35333979

Full text available

18
KLF4 is a key determinant in the development and progression of cerebral cavernous malformations
Material Type:
Article
Add to My Research

KLF4 is a key determinant in the development and progression of cerebral cavernous malformations

EMBO molecular medicine, 2016-01, Vol.8 (1), p.6-24 [Peer Reviewed Journal]

2015 The Authors. Published under the terms of the CC BY 4.0 license ;2015 The Authors. Published under the terms of the CC BY 4.0 license. ;ISSN: 1757-4676 ;ISSN: 1757-4684 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201505433 ;PMID: 26612856

Full text available

19
KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease
Material Type:
Article
Add to My Research

KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease

Antioxidants & redox signaling, 2023-03, Vol.38 (7-9), p.496-528 [Peer Reviewed Journal]

2023, Mary Ann Liebert, Inc., publishers ;Copyright Mary Ann Liebert, Inc. Mar 1, 2023 ;Copyright 2023, Mary Ann Liebert, Inc., publishers 2023 Mary Ann Liebert, Inc., publishers ;ISSN: 1523-0864 ;EISSN: 1557-7716 ;DOI: 10.1089/ars.2021.0263 ;PMID: 36047808

Full text available

20
Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice
Material Type:
Article
Add to My Research

Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice

Proceedings of the National Academy of Sciences - PNAS, 2015-07, Vol.112 (27), p.8421-8426 [Peer Reviewed Journal]

Copyright National Academy of Sciences Jul 7, 2015 ;ISSN: 0027-8424 ;ISSN: 1091-6490 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1501352112 ;PMID: 26109568

Full text available

Results 1 - 20 of 65  for All Library Resources

Results 1 2 3 4 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (64)

Refine My Results

Creation Date 

From To
  1. Before 2007  (5)
  2. 2007 To 2010  (11)
  3. 2011 To 2013  (9)
  4. 2014 To 2017  (19)
  5. After 2017  (22)
  6. More options open sub menu

Searching Remote Databases, Please Wait